View Item 

Show simple item record

Turning skin into brain: Using patient‐derived cells to model X‐linked adrenoleukodystrophy

dc.contributor.authorParent, Jack M.en_US
dc.date.accessioned2011-11-10T15:39:48Z
dc.date.available2012-11-02T18:56:54Zen_US
dc.date.issued2011-09en_US
dc.identifier.citationParent, Jack M. (2011). "Turning skin into brain: Using patient‐derived cells to model X‐linked adrenoleukodystrophy." Annals of Neurology 70(3): 350-352. <http://hdl.handle.net/2027.42/87162>en_US
dc.identifier.issn0364-5134en_US
dc.identifier.issn1531-8249en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/87162
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.titleTurning skin into brain: Using patient‐derived cells to model X‐linked adrenoleukodystrophyen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPsychiatryen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Neurology University of Michigan Medical Center, Ann Arbor, MIen_US
dc.contributor.affiliationotherVA Ann Arbor Healthcare System, Ann Arbor, MIen_US
dc.identifier.pmid21905077en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/87162/1/22546_ftp.pdf
dc.identifier.doi10.1002/ana.22546en_US
dc.identifier.sourceAnnals of Neurologyen_US
dc.identifier.citedreferenceChamberlain SJ, Li XJ, Lalande M. Induced pluripotent stem (iPS) cells as in vitro models of human neurogenetic disorders. Neurogenetics 2008; 9: 227 – 235.en_US
dc.identifier.citedreferenceTakahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663 – 676.en_US
dc.identifier.citedreferenceTakahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861 – 872.en_US
dc.identifier.citedreferenceYu J, Vodyanik MA, Smuga‐Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917 – 1920.en_US
dc.identifier.citedreferencePark IH, Arora N, Huo H, et al. Disease‐specific induced pluripotent stem cells. Cell 2008: 134; 877 – 886.en_US
dc.identifier.citedreferenceJuopperi TA, Song H, Ming GL. Modeling neurological diseases using patient‐derived induced pluripotent stem cells. Future Neurol 2011; 6: 363 – 373.en_US
dc.identifier.citedreferenceBar‐Nur O, Russ HA, Efrat S, Benvenisty N. Epigenetic memory and preferential lineage‐specific differentiation in induced pluripotent stem cells derived from human pancreatic islet Beta cells. Cell Stem Cell 2011; 9: 17 – 23.en_US
dc.identifier.citedreferenceJozefczuk J, Prigione A, Chavez L, Adjaye J. Comparative analysis of human embryonic stem cell and induced pluripotent stem cell‐derived hepatocyte‐like cells reveals current drawbacks and possible strategies for improved differentiation. Stem Cells Dev 2011; 20: 1259 – 1275.en_US
dc.identifier.citedreferenceChin MH, Mason MJ, Xie W, et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009; 5: 111 – 123.en_US
dc.identifier.citedreferenceDoi A, Park IH, Wen B, et al. Differential methylation of tissue‐ and cancer‐specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 2009; 41: 1350 – 1353.en_US
dc.identifier.citedreferenceOkita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008; 322: 949 – 953.en_US
dc.identifier.citedreferenceYu J, Smuga‐Otto K, Tian S, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009; 324: 797 – 801.en_US
dc.identifier.citedreferenceKim D, Kim CH, Moon JI, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009; 4: 472 – 476.en_US
dc.identifier.citedreferenceStadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 2008; 322: 945 – 949.en_US
dc.identifier.citedreferenceWoltjen K, Michael IP, Mohseni P, et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009; 458: 766 – 770.en_US
dc.identifier.citedreferenceKaji K, Norrby K, Paca A, et al. Virus‐free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009; 458: 771 – 775.en_US
dc.identifier.citedreferenceWarren L, Manos PD, Ahfeldt T, et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010; 7: 618 – 630.en_US
dc.identifier.citedreferenceVierbuchen T, Ostermeier A, Pang ZP, et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010; 463: 1035 – 1041.en_US
dc.identifier.citedreferencePfisterer U, Kirkeby A, Torper O, et al. Direct conversion of human fibroblasts to dopaminergic neurons. Proc Natl Acad Sci U S A 2011; 108: 10343 – 10348.en_US
dc.identifier.citedreferenceDimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008; 321: 1218 – 1221.en_US
dc.identifier.citedreferenceSoldner F, Hockemeyer D, Beard C, et al. Parkinson's disease patient‐derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009; 136: 964 – 977.en_US
dc.identifier.citedreferenceLee G, Papapetrou EP, Kim H, et al. Modelling pathogenesis and treatment of familial dysautonomia using patient‐specific iPSCs. Nature 2009; 461: 402 – 406.en_US
dc.identifier.citedreferenceChiang CH, Su Y, Wen Z, et al. Integration‐free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol Psychiatry 2011; 16: 358 – 360.en_US
dc.identifier.citedreferenceBrennand KJ, Simone A, Jou J, et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011; 473: 221 – 225.en_US
dc.identifier.citedreferenceEbert AD, Yu J, Rose FF, Jr, et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009; 457: 277 – 280.en_US
dc.identifier.citedreferenceMarchetto MC, Carromeu C, Acab A, et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010; 143: 527 – 539.en_US
dc.identifier.citedreferenceJang J, Kang HC, Kim HS, et al. Induced pluripotent stem cell models from X‐linked adrenoleukodystrophy patients. Ann Neurol 2011; 70: 402 – 409.en_US
dc.identifier.citedreferenceFerrer I, Aubourg P, Pujol A. General aspects and neuropathology of X‐linked adrenoleukodystrophy. Brain Pathol 2010; 20: 817 – 830.en_US
dc.identifier.citedreferenceMosser J, Douar AM, Sarde CO, et al. Putative X‐linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 1993; 361: 726 – 730.en_US
dc.identifier.citedreferenceBerger J, Molzer B, Fae I, Bernheimer H. X‐linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes. Biochem Biophys Res Commun 1994; 205: 1638 – 1643.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
22546_ftp.pdf
Size:
52.13KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.